Novavax COVID vaccine 90% effective in phase 3 trial umn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from umn.edu Daily Mail and Mail on Sunday newspapers.
Johnson & Johnson, Novavax boost covid vaccine hopes. What it means for India
FILE PHOTO: A woman holds a small bottle labeled with a Coronavirus COVID-19 Vaccine sticker and a medical syringe.
(REUTERS)
Share Via
Read Full Story
US pharma majors Novavax and Johnson & Johnson said that their covid vaccine candidates showed promising phase 3 trials, which would boost India s ongoing vaccination programme. Novavax has tied with Pune-based Serum Institute of India, and Johnson & Johnson has partnered with Hyderabad-based Biological E.
Novavax
1 min read
Maharashtra lockdown: Thackeray in favour if cases keep increasing, says Tope
1 min read
Covid-19 update: With 40,715 cases, India sees slight decline new infections
Novavax expects to make 150 MILLION doses of its 89% effective vaccine every MONTH from May - but the US has still not purchased any
Data from Novavax s UK trial showed it is 89.3% effective and is about 50% effective against the South African variant
CEO Stanley Erck said the firm can make 150 million doses a month for global supply by May or June
Novavax said it will be weeks before it asks for EU or UK approval
Trials are ongoing in the US where the firm is based and the federal government invested $1.6 billion in Novavax but has not purchased any doses
Novavax expects to produce 150 million vaccine doses per month as early as May: CEO yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.